|
1
|
Ross R: The pathogenesis of
atherosclerosis: A perspective for the 1990s. Nature. 362:801–809.
1993. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hansson GK and Hermansson A: The immune
system in atherosclerosis. Nat Immunol. 12:204–212. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lüscher TF and Barton M: Biology of the
endothelium. Clin Cardiol. 20(11 Suppl 2): II-3-101997.PubMed/NCBI
|
|
4
|
Olejarz W, Bryk D, Zapolska-Downar D,
Małecki M, Stachurska A and Sitkiewicz D: Mycophenolic acid
attenuates the tumour necrosis factor α-mediated proinflammatory
response in endothelial cells by blocking the MAPK/NF-κB and ROS
pathways. Eur J Clin Invest. 44:54–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pillai RS, Bhattacharyya SN and Filipowicz
W: Repression of protein synthesis by miRNAs: How many mechanisms?
Trends Cell Biol. 17:118–126. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Forman JJ and Coller HA: The code within
the code: microRNAs target coding regions. Cell Cycle. 9:1533–1541.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lytle JR, Yario TA and Steitz JA: Target
mRNAs are repressed as efficiently by microRNA-binding sites in the
5′ UTR as in the 3′UTR. Proc Natl Acad Sci USA. 104:pp. 9667–9672.
2007; View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McManus DD and Ambros V: Circulating
MicroRNAs in cardiovascular disease. Circulation. 124:1908–1910.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kosaka N, Iguchi H and Ochiya T:
Circulating microRNA in body fluid: A new potential biomarker for
cancer diagnosis and prognosis. Cancer Sci. 101:2087–2092. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cirera-Salinas D, Pauta M, Allen RM,
Salerno AG, Ramírez CM, Chamorro-Jorganes A, Wanschel AC, Lasuncion
MA, Morales-Ruiz M, Suarez Y, et al: mir-33 regulates cell
proliferation and cell cycle progression. Cell Cycle. 11:922–933.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen WJ, Yin K, Zhao GJ, Fu YC and Tang
CK: The magic and mystery of microRNA-27 in atherosclerosis.
Atherosclerosis. 222:314–323. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Torella D, Iaconetti C, Catalucci D,
Ellison GM, Leone A, Waring CD, Bochicchio A, Vicinanza C, Aquila
I, Curcio A, et al: MicroRNA-133 controls vascular smooth muscle
cell phenotypic switch in vitro and vascular remodeling in vivo.
Circ Res. 109:880–893. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meloche S, Beatty BG and Pellerin J:
Primary structure, expression and chromosomal locus of a human
homolog of rat ERK3. Oncogene. 13:1575–1579. 1996.PubMed/NCBI
|
|
15
|
Tan J, Yang L, Liu C and Yan Z:
MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell
proliferation and vein graft neointimal hyperplasia. Sci Rep.
7:466022017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tak H, Jang E, Kim SB, Park J, Suk J, Yoon
YS, Ahn JK, Lee JH and Joe CO: 14-3-3epsilon inhibits MK5-mediated
cell migration by disrupting F-actin polymerization. Cell Signal.
19:2379–2387. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Small EM and Olson EN: Pervasive roles of
microRNAs in cardiovascular biology. Nature. 469:336–342. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song Z and Li G: Role of specific
microRNAs in regulation of vascular smooth muscle cell
differentiation and the response to injury. J Cardiovasc Transl
Res. 3:246–250. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mudau M, Genis A, Lochner A and Strijdom
H: Endothelial dysfunction: The early predictor of atherosclerosis.
Cardiovasc J Afr. 23:222–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Libby P: Inflammation in atherosclerosis.
Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fish JE, Santoro MM, Morton SU, Yu S, Yeh
RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY and Srivastava D:
MiR-126 regulates angiogenic signaling and vascular integrity. Dev
Cell. 15:272–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kaufmann SH, Lee SH, Meng XW, Loegering
DA, Kottke TJ, Henzing AJ, Ruchaud S, Samejima K and Earnshaw WC:
Apoptosis-associated caspase activation assays. Methods.
44:262–272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Marsden VS, O'Connor L, O'Reilly LA, Silke
J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ,
et al: Apoptosis initiated by Bcl-2-regulated caspase activation
independently of the cytochrome c/Apaf-1/caspase-9 apoptosome.
Nature. 419:634–637. 2002. View Article : Google Scholar : PubMed/NCBI
|
